Whether your laboratory specializes in automated high throughput or clinic-level prenatal screening, we meet the needs of your screening program from sample to report. Our prenatal serum screening solutions and the latest advances in prenatal care.
We offer screening systems for aneuploidies that combine markers and assays for high detection rates with low numbers of false positives. PerkinElmer is the only company to offer four CE-marked assays – PAPP-A, free hCGß, PlGF and AFP – for first trimester screening of Down syndrome.
Our screening tests are based on biochemical markers from maternal serum and provide expectant parents with a risk assessment for trisomy 21, 13, and 18. In addition to screening for the common aneuploidies, our solutions can facilitate early detection of other conditions; our AutoDELFIA®, DELFIA® and DELFIA® Xpress hAFP kits, for example, can be used to determine neural tube defects in the absence of NT measurement.
Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.
